Small molecules are estimated at 58.0% by product type in 2026, with continuous manufacturing at 31.0% and tablets at 30.0%. Adoption depends on lower solvent and energy intensity without weakening validated quality or regulatory comparability during scale-up.
Sustainable Drug Manufacturing Market Analysis By End UserSustainable Drug Manufacturing Market Analysis By FormulationSustainable Drug Manufacturing Market Analysis By Process TypeSustainable Drug Manufacturing Market Analysis By TechnologySustainable Drug Manufacturing Market Opportunity Matrix Growth Vs ValueSustainable Drug Manufacturing Market Breakdown By Product Type, Process Type, And Region